nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NR0B1—seminiferous tubule of testis—testicular cancer	0.0954	0.271	CbGeAlD
Vorinostat—NCOR1—Ovarian Infertility Genes—DAZL—testicular cancer	0.0485	0.167	CbGpPWpGaD
Vorinostat—HDAC6—Ectoderm Differentiation—TFAP2C—testicular cancer	0.0134	0.0462	CbGpPWpGaD
Vorinostat—HDAC3—embryo—testicular cancer	0.0111	0.0316	CbGeAlD
Vorinostat—HDAC3—seminal vesicle—testicular cancer	0.0104	0.0297	CbGeAlD
Vorinostat—HDAC1—embryo—testicular cancer	0.0102	0.029	CbGeAlD
Vorinostat—HDAC4—gonad—testicular cancer	0.00989	0.0281	CbGeAlD
Vorinostat—HDAC1—seminal vesicle—testicular cancer	0.00957	0.0272	CbGeAlD
Vorinostat—HDAC6—female gonad—testicular cancer	0.00932	0.0265	CbGeAlD
Vorinostat—HDAC11—gonad—testicular cancer	0.00888	0.0252	CbGeAlD
Vorinostat—NCOR1—gonad—testicular cancer	0.00861	0.0245	CbGeAlD
Vorinostat—HDAC6—testis—testicular cancer	0.00827	0.0235	CbGeAlD
Vorinostat—HDAC8—female gonad—testicular cancer	0.00827	0.0235	CbGeAlD
Vorinostat—NR0B1—gonad—testicular cancer	0.00808	0.023	CbGeAlD
Vorinostat—HDAC4—female gonad—testicular cancer	0.00804	0.0228	CbGeAlD
Vorinostat—HDAC8—testis—testicular cancer	0.00733	0.0209	CbGeAlD
Vorinostat—HDAC11—female gonad—testicular cancer	0.00721	0.0205	CbGeAlD
Vorinostat—HDAC4—testis—testicular cancer	0.00713	0.0203	CbGeAlD
Vorinostat—NCOR1—female gonad—testicular cancer	0.007	0.0199	CbGeAlD
Vorinostat—HDAC1—gonad—testicular cancer	0.00691	0.0197	CbGeAlD
Vorinostat—NR0B1—female gonad—testicular cancer	0.00657	0.0187	CbGeAlD
Vorinostat—HDAC2—Teniposide—Etoposide—testicular cancer	0.00656	1	CbGdCrCtD
Vorinostat—HDAC11—testis—testicular cancer	0.0064	0.0182	CbGeAlD
Vorinostat—NCOR1—testis—testicular cancer	0.00621	0.0176	CbGeAlD
Vorinostat—HDAC3—female gonad—testicular cancer	0.00613	0.0174	CbGeAlD
Vorinostat—HDAC6—lymph node—testicular cancer	0.00599	0.017	CbGeAlD
Vorinostat—HDAC6—Cell Cycle—MAD1L1—testicular cancer	0.00595	0.0205	CbGpPWpGaD
Vorinostat—NR0B1—testis—testicular cancer	0.00583	0.0166	CbGeAlD
Vorinostat—HDAC1—female gonad—testicular cancer	0.00562	0.016	CbGeAlD
Vorinostat—HDAC9—female gonad—testicular cancer	0.00553	0.0157	CbGeAlD
Vorinostat—HDAC3—testis—testicular cancer	0.00544	0.0155	CbGeAlD
Vorinostat—HDAC1—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.0054	0.0186	CbGpPWpGaD
Vorinostat—HDAC4—Cell Cycle—MAD1L1—testicular cancer	0.00538	0.0185	CbGpPWpGaD
Vorinostat—HDAC8—lymph node—testicular cancer	0.00532	0.0151	CbGeAlD
Vorinostat—HDAC4—lymph node—testicular cancer	0.00517	0.0147	CbGeAlD
Vorinostat—HDAC2—embryo—testicular cancer	0.00512	0.0146	CbGeAlD
Vorinostat—HDAC8—Resolution of Sister Chromatid Cohesion—MAD1L1—testicular cancer	0.00505	0.0174	CbGpPWpGaD
Vorinostat—HDAC1—testis—testicular cancer	0.00498	0.0142	CbGeAlD
Vorinostat—HDAC8—Cell Cycle—MAD1L1—testicular cancer	0.00497	0.0171	CbGpPWpGaD
Vorinostat—HDAC9—testis—testicular cancer	0.0049	0.0139	CbGeAlD
Vorinostat—HDAC8—Mitotic Prometaphase—MAD1L1—testicular cancer	0.00475	0.0163	CbGpPWpGaD
Vorinostat—HDAC11—lymph node—testicular cancer	0.00464	0.0132	CbGeAlD
Vorinostat—NCOR1—lymph node—testicular cancer	0.0045	0.0128	CbGeAlD
Vorinostat—NCOR1—C-MYB transcription factor network—MAD1L1—testicular cancer	0.00448	0.0154	CbGpPWpGaD
Vorinostat—HDAC3—Cell Cycle—MAD1L1—testicular cancer	0.00417	0.0144	CbGpPWpGaD
Vorinostat—HDAC3—lymph node—testicular cancer	0.00394	0.0112	CbGeAlD
Vorinostat—HDAC6—Cell Cycle—KITLG—testicular cancer	0.00382	0.0131	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—PRDM14—testicular cancer	0.00381	0.0131	CbGpPWpGaD
Vorinostat—HDAC4—Endochondral Ossification—FGFR3—testicular cancer	0.00373	0.0128	CbGpPWpGaD
Vorinostat—HDAC1—lymph node—testicular cancer	0.00361	0.0103	CbGeAlD
Vorinostat—HDAC9—lymph node—testicular cancer	0.00355	0.0101	CbGeAlD
Vorinostat—NCOR1—Developmental Biology—PRDM14—testicular cancer	0.0035	0.012	CbGpPWpGaD
Vorinostat—HDAC2—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.00348	0.012	CbGpPWpGaD
Vorinostat—HDAC2—gonad—testicular cancer	0.00348	0.00988	CbGeAlD
Vorinostat—HDAC8—Separation of Sister Chromatids—MAD1L1—testicular cancer	0.00347	0.0119	CbGpPWpGaD
Vorinostat—HDAC4—Cell Cycle—KITLG—testicular cancer	0.00345	0.0119	CbGpPWpGaD
Vorinostat—HDAC11—Neural Crest Differentiation—FGFR3—testicular cancer	0.00341	0.0117	CbGpPWpGaD
Vorinostat—HDAC8—Mitotic Anaphase—MAD1L1—testicular cancer	0.00329	0.0113	CbGpPWpGaD
Vorinostat—HDAC8—Mitotic Metaphase and Anaphase—MAD1L1—testicular cancer	0.00327	0.0113	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—KITLG—testicular cancer	0.00319	0.011	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—MAD1L1—testicular cancer	0.00313	0.0108	CbGpPWpGaD
Vorinostat—NCOR1—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00312	0.0107	CbGpPWpGaD
Vorinostat—NCOR1—C-MYB transcription factor network—KITLG—testicular cancer	0.00287	0.00989	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00287	0.00987	CbGpPWpGaD
Vorinostat—HDAC6—Neural Crest Differentiation—FGFR3—testicular cancer	0.00286	0.00984	CbGpPWpGaD
Vorinostat—HDAC2—female gonad—testicular cancer	0.00282	0.00803	CbGeAlD
Vorinostat—HDAC3—Cell Cycle—KITLG—testicular cancer	0.00268	0.00921	CbGpPWpGaD
Vorinostat—HDAC4—Neural Crest Differentiation—FGFR3—testicular cancer	0.00259	0.0089	CbGpPWpGaD
Vorinostat—HDAC2—testis—testicular cancer	0.00251	0.00712	CbGeAlD
Vorinostat—HDAC1—Retinoblastoma (RB) in Cancer—H2AFZ—testicular cancer	0.00248	0.00852	CbGpPWpGaD
Vorinostat—HDAC1—formation of the beta-catenin:TCF transactivating complex—H2AFZ—testicular cancer	0.00248	0.00852	CbGpPWpGaD
Vorinostat—HDAC8—Neural Crest Differentiation—FGFR3—testicular cancer	0.00239	0.00821	CbGpPWpGaD
Vorinostat—HDAC9—Neural Crest Differentiation—FGFR3—testicular cancer	0.00223	0.00768	CbGpPWpGaD
Vorinostat—HDAC1—NoRC negatively regulates rRNA expression—H2AFZ—testicular cancer	0.00218	0.0075	CbGpPWpGaD
Vorinostat—HDAC1—RNA Polymerase I Promoter Clearance—H2AFZ—testicular cancer	0.00213	0.00733	CbGpPWpGaD
Vorinostat—HDAC1—Negative epigenetic regulation of rRNA expression—H2AFZ—testicular cancer	0.00213	0.00733	CbGpPWpGaD
Vorinostat—HDAC8—M Phase—MAD1L1—testicular cancer	0.00212	0.00731	CbGpPWpGaD
Vorinostat—HDAC1—RNA Polymerase I Transcription—H2AFZ—testicular cancer	0.0021	0.00722	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.00209	0.00717	CbGpPWpGaD
Vorinostat—HDAC2—Cell Cycle—MAD1L1—testicular cancer	0.00202	0.00693	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—KITLG—testicular cancer	0.00201	0.0069	CbGpPWpGaD
Vorinostat—HDAC3—Neural Crest Differentiation—FGFR3—testicular cancer	0.00201	0.0069	CbGpPWpGaD
Vorinostat—NCOR1—C-MYB transcription factor network—KIT—testicular cancer	0.00196	0.00675	CbGpPWpGaD
Vorinostat—HDAC8—Mitotic M-M/G1 phases—MAD1L1—testicular cancer	0.00195	0.0067	CbGpPWpGaD
Vorinostat—HDAC6—Cellular responses to stress—H2AFZ—testicular cancer	0.00194	0.00667	CbGpPWpGaD
Vorinostat—HDAC8—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00189	0.00651	CbGpPWpGaD
Vorinostat—HDAC1—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.00189	0.0065	CbGpPWpGaD
Vorinostat—HDAC2—lymph node—testicular cancer	0.00182	0.00516	CbGeAlD
Vorinostat—NCOR1—Signaling by ERBB4—KITLG—testicular cancer	0.00179	0.00615	CbGpPWpGaD
Vorinostat—HDAC1—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—H2AFZ—testicular cancer	0.00167	0.00576	CbGpPWpGaD
Vorinostat—HDAC3—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00159	0.00547	CbGpPWpGaD
Vorinostat—HDAC1—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.00158	0.00545	CbGpPWpGaD
Vorinostat—HDAC1—Neural Crest Differentiation—FGFR3—testicular cancer	0.0015	0.00517	CbGpPWpGaD
Vorinostat—HDAC8—M Phase—H2AFZ—testicular cancer	0.00148	0.0051	CbGpPWpGaD
Vorinostat—HDAC1—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.00147	0.00507	CbGpPWpGaD
Vorinostat—NCOR1—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00146	0.00503	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—INSL3—testicular cancer	0.00146	0.00501	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle, Mitotic—MAD1L1—testicular cancer	0.00146	0.00501	CbGpPWpGaD
Vorinostat—Neutropenia—Dactinomycin—testicular cancer	0.00145	0.00412	CcSEcCtD
Vorinostat—Embolism—Doxorubicin—testicular cancer	0.00144	0.00411	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.00141	0.00403	CcSEcCtD
Vorinostat—HDAC2—NoRC negatively regulates rRNA expression—H2AFZ—testicular cancer	0.0014	0.00483	CbGpPWpGaD
Vorinostat—Alopecia—Vinblastine—testicular cancer	0.00139	0.00396	CcSEcCtD
Vorinostat—Anaemia—Chlorambucil—testicular cancer	0.00138	0.00393	CcSEcCtD
Vorinostat—HDAC2—RNA Polymerase I Promoter Clearance—H2AFZ—testicular cancer	0.00137	0.00472	CbGpPWpGaD
Vorinostat—HDAC2—Negative epigenetic regulation of rRNA expression—H2AFZ—testicular cancer	0.00137	0.00472	CbGpPWpGaD
Vorinostat—Angioedema—Chlorambucil—testicular cancer	0.00136	0.00389	CcSEcCtD
Vorinostat—HDAC8—Mitotic M-M/G1 phases—H2AFZ—testicular cancer	0.00136	0.00467	CbGpPWpGaD
Vorinostat—HDAC2—RNA Polymerase I Transcription—H2AFZ—testicular cancer	0.00135	0.00465	CbGpPWpGaD
Vorinostat—Abscess—Methotrexate—testicular cancer	0.00135	0.00385	CcSEcCtD
Vorinostat—Pancytopenia—Ifosfamide—testicular cancer	0.00135	0.00383	CcSEcCtD
Vorinostat—Leukopenia—Chlorambucil—testicular cancer	0.00134	0.00381	CcSEcCtD
Vorinostat—NCOR1—Signaling by ERBB4—FGFR3—testicular cancer	0.00133	0.00457	CbGpPWpGaD
Vorinostat—Blood creatinine increased—Cisplatin—testicular cancer	0.00132	0.00377	CcSEcCtD
Vorinostat—Dehydration—Cisplatin—testicular cancer	0.00131	0.00375	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—MAD1L1—testicular cancer	0.0013	0.00448	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—DNMT3L—testicular cancer	0.0013	0.00448	CbGpPWpGaD
Vorinostat—HDAC2—Cell Cycle—KITLG—testicular cancer	0.00129	0.00445	CbGpPWpGaD
Vorinostat—Hypokalaemia—Cisplatin—testicular cancer	0.00129	0.00367	CcSEcCtD
Vorinostat—Hyperglycaemia—Ifosfamide—testicular cancer	0.00128	0.00364	CcSEcCtD
Vorinostat—Anaemia—Vinblastine—testicular cancer	0.00126	0.0036	CcSEcCtD
Vorinostat—Abscess—Epirubicin—testicular cancer	0.00126	0.0036	CcSEcCtD
Vorinostat—Acute coronary syndrome—Ifosfamide—testicular cancer	0.00125	0.00355	CcSEcCtD
Vorinostat—Myocardial infarction—Ifosfamide—testicular cancer	0.00124	0.00353	CcSEcCtD
Vorinostat—Leukopenia—Vinblastine—testicular cancer	0.00122	0.00349	CcSEcCtD
Vorinostat—HDAC6—Signaling Pathways—INSL3—testicular cancer	0.00122	0.0042	CbGpPWpGaD
Vorinostat—NCOR1—Signaling by ERBB4—KIT—testicular cancer	0.00122	0.0042	CbGpPWpGaD
Vorinostat—HDAC2—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.00122	0.00419	CbGpPWpGaD
Vorinostat—Proteinuria—Methotrexate—testicular cancer	0.00122	0.00347	CcSEcCtD
Vorinostat—Infection—Chlorambucil—testicular cancer	0.00121	0.00345	CcSEcCtD
Vorinostat—Protein urine present—Methotrexate—testicular cancer	0.0012	0.00342	CcSEcCtD
Vorinostat—Thrombocytopenia—Chlorambucil—testicular cancer	0.00119	0.0034	CcSEcCtD
Vorinostat—HDAC1—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00119	0.0041	CbGpPWpGaD
Vorinostat—Chills—Bleomycin—testicular cancer	0.00119	0.00339	CcSEcCtD
Vorinostat—HDAC1—TCF dependent signaling in response to WNT—H2AFZ—testicular cancer	0.00119	0.00408	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—KITLG—testicular cancer	0.00117	0.00404	CbGpPWpGaD
Vorinostat—Alopecia—Bleomycin—testicular cancer	0.00117	0.00334	CcSEcCtD
Vorinostat—Neoplasm malignant—Epirubicin—testicular cancer	0.00117	0.00334	CcSEcCtD
Vorinostat—Abscess—Doxorubicin—testicular cancer	0.00117	0.00333	CcSEcCtD
Vorinostat—Anorexia—Chlorambucil—testicular cancer	0.00116	0.00331	CcSEcCtD
Vorinostat—Pancytopenia—Cisplatin—testicular cancer	0.00116	0.00331	CcSEcCtD
Vorinostat—HDAC1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.00115	0.00395	CbGpPWpGaD
Vorinostat—HDAC1—Transcription—H2AFZ—testicular cancer	0.00113	0.0039	CbGpPWpGaD
Vorinostat—Chills—Dactinomycin—testicular cancer	0.00111	0.00316	CcSEcCtD
Vorinostat—NCOR1—Gene Expression—DNMT3L—testicular cancer	0.00111	0.00381	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—INSL3—testicular cancer	0.0011	0.0038	CbGpPWpGaD
Vorinostat—Alopecia—Dactinomycin—testicular cancer	0.00109	0.00312	CcSEcCtD
Vorinostat—Thrombocytopenia—Vinblastine—testicular cancer	0.00109	0.00311	CcSEcCtD
Vorinostat—Neoplasm malignant—Doxorubicin—testicular cancer	0.00108	0.00309	CcSEcCtD
Vorinostat—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—H2AFZ—testicular cancer	0.00108	0.00371	CbGpPWpGaD
Vorinostat—Acute coronary syndrome—Cisplatin—testicular cancer	0.00107	0.00306	CcSEcCtD
Vorinostat—Pulmonary embolism—Methotrexate—testicular cancer	0.00107	0.00304	CcSEcCtD
Vorinostat—Anaemia—Bleomycin—testicular cancer	0.00107	0.00304	CcSEcCtD
Vorinostat—Myocardial infarction—Cisplatin—testicular cancer	0.00107	0.00304	CcSEcCtD
Vorinostat—HDAC1—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.00107	0.00367	CbGpPWpGaD
Vorinostat—Anorexia—Vinblastine—testicular cancer	0.00106	0.00303	CcSEcCtD
Vorinostat—Pancytopenia—Etoposide—testicular cancer	0.00106	0.00303	CcSEcCtD
Vorinostat—Decreased appetite—Chlorambucil—testicular cancer	0.00106	0.00302	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00105	0.003	CcSEcCtD
Vorinostat—Fatigue—Chlorambucil—testicular cancer	0.00105	0.00299	CcSEcCtD
Vorinostat—Neutropenia—Etoposide—testicular cancer	0.00105	0.00298	CcSEcCtD
Vorinostat—Leukopenia—Bleomycin—testicular cancer	0.00103	0.00295	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—INSL3—testicular cancer	0.00102	0.0035	CbGpPWpGaD
Vorinostat—Chills—Ifosfamide—testicular cancer	0.00102	0.0029	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle, Mitotic—H2AFZ—testicular cancer	0.00102	0.00349	CbGpPWpGaD
Vorinostat—Cough—Bleomycin—testicular cancer	0.00101	0.00287	CcSEcCtD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00101	0.00346	CbGpPWpGaD
Vorinostat—Alopecia—Ifosfamide—testicular cancer	0.001	0.00286	CcSEcCtD
Vorinostat—Pulmonary embolism—Epirubicin—testicular cancer	0.001	0.00285	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—testicular cancer	0.000996	0.00284	CcSEcCtD
Vorinostat—Acute coronary syndrome—Etoposide—testicular cancer	0.000984	0.0028	CcSEcCtD
Vorinostat—Chest pain—Bleomycin—testicular cancer	0.000984	0.0028	CcSEcCtD
Vorinostat—Myocardial infarction—Etoposide—testicular cancer	0.000978	0.00279	CcSEcCtD
Vorinostat—Decreased appetite—Vinblastine—testicular cancer	0.000971	0.00277	CcSEcCtD
Vorinostat—HDAC2—Neural Crest Differentiation—FGFR3—testicular cancer	0.000968	0.00333	CbGpPWpGaD
Vorinostat—Leukopenia—Dactinomycin—testicular cancer	0.000965	0.00275	CcSEcCtD
Vorinostat—Body temperature increased—Chlorambucil—testicular cancer	0.000963	0.00274	CcSEcCtD
Vorinostat—Constipation—Vinblastine—testicular cancer	0.000955	0.00272	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—INSL3—testicular cancer	0.000953	0.00328	CbGpPWpGaD
Vorinostat—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.000949	0.00327	CbGpPWpGaD
Vorinostat—Infection—Bleomycin—testicular cancer	0.000937	0.00267	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—testicular cancer	0.000927	0.00264	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—testicular cancer	0.000925	0.00264	CcSEcCtD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000925	0.00318	CbGpPWpGaD
Vorinostat—Thrombocytopenia—Bleomycin—testicular cancer	0.000923	0.00263	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle, Mitotic—MAD1L1—testicular cancer	0.000917	0.00315	CbGpPWpGaD
Vorinostat—Anaemia—Ifosfamide—testicular cancer	0.000913	0.0026	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—H2AFZ—testicular cancer	0.000908	0.00312	CbGpPWpGaD
Vorinostat—Angioedema—Ifosfamide—testicular cancer	0.000902	0.00257	CcSEcCtD
Vorinostat—HDAC1—Gene Expression—DNMT3L—testicular cancer	0.000902	0.0031	CbGpPWpGaD
Vorinostat—Anorexia—Bleomycin—testicular cancer	0.000899	0.00256	CcSEcCtD
Vorinostat—Leukopenia—Ifosfamide—testicular cancer	0.000884	0.00252	CcSEcCtD
Vorinostat—HDAC1—Signaling by Wnt—H2AFZ—testicular cancer	0.00088	0.00303	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—KITLG—testicular cancer	0.000879	0.00302	CbGpPWpGaD
Vorinostat—Asthenia—Chlorambucil—testicular cancer	0.000874	0.00249	CcSEcCtD
Vorinostat—Infection—Dactinomycin—testicular cancer	0.000874	0.00249	CcSEcCtD
Vorinostat—HDAC3—Signaling by NGF—FGFR3—testicular cancer	0.000872	0.003	CbGpPWpGaD
Vorinostat—Sepsis—Epirubicin—testicular cancer	0.000868	0.00247	CcSEcCtD
Vorinostat—Alopecia—Cisplatin—testicular cancer	0.000864	0.00246	CcSEcCtD
Vorinostat—Pruritus—Chlorambucil—testicular cancer	0.000862	0.00246	CcSEcCtD
Vorinostat—Cough—Ifosfamide—testicular cancer	0.000862	0.00246	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—testicular cancer	0.000861	0.00245	CcSEcCtD
Vorinostat—HDAC3—Signaling Pathways—INSL3—testicular cancer	0.000856	0.00294	CbGpPWpGaD
Vorinostat—Chest pain—Ifosfamide—testicular cancer	0.000841	0.0024	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—testicular cancer	0.000838	0.00239	CcSEcCtD
Vorinostat—Diarrhoea—Chlorambucil—testicular cancer	0.000834	0.00238	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000822	0.00234	CcSEcCtD
Vorinostat—Decreased appetite—Bleomycin—testicular cancer	0.00082	0.00234	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle—MAD1L1—testicular cancer	0.00082	0.00282	CbGpPWpGaD
Vorinostat—Muscle spasms—Cisplatin—testicular cancer	0.000819	0.00233	CcSEcCtD
Vorinostat—Chills—Etoposide—testicular cancer	0.000804	0.00229	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—testicular cancer	0.000803	0.00229	CcSEcCtD
Vorinostat—Asthenia—Vinblastine—testicular cancer	0.000801	0.00228	CcSEcCtD
Vorinostat—HDAC3—Signaling by NGF—KIT—testicular cancer	0.000801	0.00275	CbGpPWpGaD
Vorinostat—Infection—Ifosfamide—testicular cancer	0.000801	0.00228	CcSEcCtD
Vorinostat—Alopecia—Etoposide—testicular cancer	0.000792	0.00226	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—testicular cancer	0.000792	0.00226	CcSEcCtD
Vorinostat—Thrombocytopenia—Ifosfamide—testicular cancer	0.000789	0.00225	CcSEcCtD
Vorinostat—Anaemia—Cisplatin—testicular cancer	0.000787	0.00224	CcSEcCtD
Vorinostat—NCOR1—Signaling Pathways—INSL3—testicular cancer	0.000787	0.00271	CbGpPWpGaD
Vorinostat—Vomiting—Chlorambucil—testicular cancer	0.000775	0.00221	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000769	0.00219	CcSEcCtD
Vorinostat—Anorexia—Ifosfamide—testicular cancer	0.000768	0.00219	CcSEcCtD
Vorinostat—HDAC2—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.000768	0.00264	CbGpPWpGaD
Vorinostat—Decreased appetite—Dactinomycin—testicular cancer	0.000765	0.00218	CcSEcCtD
Vorinostat—Diarrhoea—Vinblastine—testicular cancer	0.000764	0.00218	CcSEcCtD
Vorinostat—Dysgeusia—Etoposide—testicular cancer	0.000764	0.00218	CcSEcCtD
Vorinostat—Leukopenia—Cisplatin—testicular cancer	0.000762	0.00217	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—testicular cancer	0.000758	0.00216	CcSEcCtD
Vorinostat—Muscle spasms—Etoposide—testicular cancer	0.00075	0.00214	CcSEcCtD
Vorinostat—Body temperature increased—Bleomycin—testicular cancer	0.000746	0.00212	CcSEcCtD
Vorinostat—Lethargy—Epirubicin—testicular cancer	0.000741	0.00211	CcSEcCtD
Vorinostat—Dizziness—Vinblastine—testicular cancer	0.000738	0.0021	CcSEcCtD
Vorinostat—HDAC2—Transcription—H2AFZ—testicular cancer	0.000731	0.00251	CbGpPWpGaD
Vorinostat—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000726	0.00207	CcSEcCtD
Vorinostat—Nausea—Chlorambucil—testicular cancer	0.000724	0.00206	CcSEcCtD
Vorinostat—Anaemia—Etoposide—testicular cancer	0.000721	0.00205	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000712	0.00203	CcSEcCtD
Vorinostat—Vomiting—Vinblastine—testicular cancer	0.00071	0.00202	CcSEcCtD
Vorinostat—Decreased appetite—Ifosfamide—testicular cancer	0.000701	0.002	CcSEcCtD
Vorinostat—Headache—Vinblastine—testicular cancer	0.0007	0.00199	CcSEcCtD
Vorinostat—Leukopenia—Etoposide—testicular cancer	0.000698	0.00199	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000696	0.00198	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—testicular cancer	0.000695	0.00198	CcSEcCtD
Vorinostat—Fatigue—Ifosfamide—testicular cancer	0.000695	0.00198	CcSEcCtD
Vorinostat—Infection—Cisplatin—testicular cancer	0.00069	0.00197	CcSEcCtD
Vorinostat—Constipation—Ifosfamide—testicular cancer	0.000689	0.00196	CcSEcCtD
Vorinostat—Loss of consciousness—Etoposide—testicular cancer	0.000686	0.00195	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—testicular cancer	0.000686	0.00195	CcSEcCtD
Vorinostat—Cough—Etoposide—testicular cancer	0.000681	0.00194	CcSEcCtD
Vorinostat—Thrombocytopenia—Cisplatin—testicular cancer	0.00068	0.00194	CcSEcCtD
Vorinostat—Blood creatinine increased—Epirubicin—testicular cancer	0.00068	0.00194	CcSEcCtD
Vorinostat—Asthenia—Bleomycin—testicular cancer	0.000677	0.00193	CcSEcCtD
Vorinostat—Dehydration—Epirubicin—testicular cancer	0.000675	0.00192	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000672	0.00191	CcSEcCtD
Vorinostat—Pruritus—Bleomycin—testicular cancer	0.000667	0.0019	CcSEcCtD
Vorinostat—HDAC11—Disease—H2AFZ—testicular cancer	0.000666	0.00229	CbGpPWpGaD
Vorinostat—Chest pain—Etoposide—testicular cancer	0.000664	0.00189	CcSEcCtD
Vorinostat—Nausea—Vinblastine—testicular cancer	0.000663	0.00189	CcSEcCtD
Vorinostat—Anorexia—Cisplatin—testicular cancer	0.000662	0.00189	CcSEcCtD
Vorinostat—Hypokalaemia—Epirubicin—testicular cancer	0.000661	0.00188	CcSEcCtD
Vorinostat—HDAC1—Signaling by NGF—FGFR3—testicular cancer	0.000653	0.00225	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—INSL3—testicular cancer	0.000641	0.00221	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—H2AFZ—testicular cancer	0.000639	0.0022	CbGpPWpGaD
Vorinostat—Body temperature increased—Ifosfamide—testicular cancer	0.000637	0.00182	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—testicular cancer	0.000637	0.00181	CcSEcCtD
Vorinostat—Infection—Etoposide—testicular cancer	0.000632	0.0018	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—testicular cancer	0.000631	0.0018	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—testicular cancer	0.000629	0.00179	CcSEcCtD
Vorinostat—Neutropenia—Methotrexate—testicular cancer	0.000627	0.00179	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—testicular cancer	0.000625	0.00178	CcSEcCtD
Vorinostat—Thrombocytopenia—Etoposide—testicular cancer	0.000623	0.00178	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000623	0.00178	CcSEcCtD
Vorinostat—HDAC11—Disease—KITLG—testicular cancer	0.000613	0.00211	CbGpPWpGaD
Vorinostat—Hypokalaemia—Doxorubicin—testicular cancer	0.000611	0.00174	CcSEcCtD
Vorinostat—Anorexia—Etoposide—testicular cancer	0.000607	0.00173	CcSEcCtD
Vorinostat—HDAC2—Direct p53 effectors—MMP2—testicular cancer	0.000607	0.00209	CbGpPWpGaD
Vorinostat—Decreased appetite—Cisplatin—testicular cancer	0.000604	0.00172	CcSEcCtD
Vorinostat—Diarrhoea—Dactinomycin—testicular cancer	0.000602	0.00171	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Cisplatin—testicular cancer	0.0006	0.00171	CcSEcCtD
Vorinostat—HDAC1—Signaling by NGF—KIT—testicular cancer	0.0006	0.00206	CbGpPWpGaD
Vorinostat—Vomiting—Bleomycin—testicular cancer	0.0006	0.00171	CcSEcCtD
Vorinostat—Pancytopenia—Epirubicin—testicular cancer	0.000596	0.0017	CcSEcCtD
Vorinostat—Neutropenia—Epirubicin—testicular cancer	0.000587	0.00167	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000583	0.00166	CcSEcCtD
Vorinostat—HDAC2—Gene Expression—DNMT3L—testicular cancer	0.000581	0.002	CbGpPWpGaD
Vorinostat—Asthenia—Ifosfamide—testicular cancer	0.000578	0.00165	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle—H2AFZ—testicular cancer	0.000571	0.00197	CbGpPWpGaD
Vorinostat—Pruritus—Ifosfamide—testicular cancer	0.00057	0.00162	CcSEcCtD
Vorinostat—Weight decreased—Epirubicin—testicular cancer	0.000568	0.00162	CcSEcCtD
Vorinostat—HDAC2—Signaling by NGF—KITLG—testicular cancer	0.000566	0.00195	CbGpPWpGaD
Vorinostat—Hyperglycaemia—Epirubicin—testicular cancer	0.000566	0.00161	CcSEcCtD
Vorinostat—Nausea—Bleomycin—testicular cancer	0.00056	0.0016	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—testicular cancer	0.000559	0.00159	CcSEcCtD
Vorinostat—HDAC6—Disease—H2AFZ—testicular cancer	0.000558	0.00192	CbGpPWpGaD
Vorinostat—Decreased appetite—Etoposide—testicular cancer	0.000553	0.00158	CcSEcCtD
Vorinostat—Diarrhoea—Ifosfamide—testicular cancer	0.000551	0.00157	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—testicular cancer	0.000551	0.00157	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Etoposide—testicular cancer	0.00055	0.00157	CcSEcCtD
Vorinostat—Body temperature increased—Cisplatin—testicular cancer	0.000549	0.00156	CcSEcCtD
Vorinostat—Fatigue—Etoposide—testicular cancer	0.000549	0.00156	CcSEcCtD
Vorinostat—Constipation—Etoposide—testicular cancer	0.000544	0.00155	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—testicular cancer	0.000543	0.00155	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00054	0.00154	CcSEcCtD
Vorinostat—Dizziness—Ifosfamide—testicular cancer	0.000533	0.00152	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—testicular cancer	0.000525	0.0015	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—testicular cancer	0.000524	0.00149	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—testicular cancer	0.000522	0.00149	CcSEcCtD
Vorinostat—HDAC6—Disease—KITLG—testicular cancer	0.000513	0.00177	CbGpPWpGaD
Vorinostat—Vomiting—Ifosfamide—testicular cancer	0.000512	0.00146	CcSEcCtD
Vorinostat—HDAC4—Disease—H2AFZ—testicular cancer	0.000505	0.00174	CbGpPWpGaD
Vorinostat—Body temperature increased—Etoposide—testicular cancer	0.000503	0.00143	CcSEcCtD
Vorinostat—Asthenia—Cisplatin—testicular cancer	0.000499	0.00142	CcSEcCtD
Vorinostat—Oedema peripheral—Epirubicin—testicular cancer	0.000495	0.00141	CcSEcCtD
Vorinostat—Chills—Methotrexate—testicular cancer	0.000482	0.00137	CcSEcCtD
Vorinostat—Nausea—Ifosfamide—testicular cancer	0.000479	0.00136	CcSEcCtD
Vorinostat—Diarrhoea—Cisplatin—testicular cancer	0.000475	0.00135	CcSEcCtD
Vorinostat—Alopecia—Methotrexate—testicular cancer	0.000474	0.00135	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—H2AFZ—testicular cancer	0.000466	0.0016	CbGpPWpGaD
Vorinostat—HDAC8—Disease—H2AFZ—testicular cancer	0.000466	0.0016	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KITLG—testicular cancer	0.000464	0.0016	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—STK11—testicular cancer	0.000464	0.00159	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—MMP2—testicular cancer	0.000458	0.00158	CbGpPWpGaD
Vorinostat—Oedema peripheral—Doxorubicin—testicular cancer	0.000458	0.0013	CcSEcCtD
Vorinostat—Dysgeusia—Methotrexate—testicular cancer	0.000458	0.0013	CcSEcCtD
Vorinostat—Asthenia—Etoposide—testicular cancer	0.000457	0.0013	CcSEcCtD
Vorinostat—NR0B1—Gene Expression—H2AFZ—testicular cancer	0.000455	0.00157	CbGpPWpGaD
Vorinostat—HDAC11—Disease—FGFR3—testicular cancer	0.000455	0.00157	CbGpPWpGaD
Vorinostat—Chills—Epirubicin—testicular cancer	0.000451	0.00128	CcSEcCtD
Vorinostat—Pruritus—Etoposide—testicular cancer	0.00045	0.00128	CcSEcCtD
Vorinostat—HDAC3—Metabolism—HPGDS—testicular cancer	0.000448	0.00154	CbGpPWpGaD
Vorinostat—Alopecia—Epirubicin—testicular cancer	0.000444	0.00126	CcSEcCtD
Vorinostat—Vomiting—Cisplatin—testicular cancer	0.000442	0.00126	CcSEcCtD
Vorinostat—HDAC9—Disease—H2AFZ—testicular cancer	0.000436	0.0015	CbGpPWpGaD
Vorinostat—Diarrhoea—Etoposide—testicular cancer	0.000436	0.00124	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—testicular cancer	0.000432	0.00123	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—KITLG—testicular cancer	0.000429	0.00148	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KITLG—testicular cancer	0.000428	0.00147	CbGpPWpGaD
Vorinostat—Dysgeusia—Epirubicin—testicular cancer	0.000428	0.00122	CcSEcCtD
Vorinostat—NCOR1—Developmental Biology—MMP2—testicular cancer	0.000421	0.00145	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—FGFR3—testicular cancer	0.000421	0.00145	CbGpPWpGaD
Vorinostat—Dizziness—Etoposide—testicular cancer	0.000421	0.0012	CcSEcCtD
Vorinostat—Muscle spasms—Epirubicin—testicular cancer	0.00042	0.0012	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—testicular cancer	0.000418	0.00119	CcSEcCtD
Vorinostat—HDAC11—Disease—KIT—testicular cancer	0.000418	0.00144	CbGpPWpGaD
Vorinostat—Chills—Doxorubicin—testicular cancer	0.000417	0.00119	CcSEcCtD
Vorinostat—HDAC2—Signaling Pathways—INSL3—testicular cancer	0.000413	0.00142	CbGpPWpGaD
Vorinostat—Nausea—Cisplatin—testicular cancer	0.000413	0.00118	CcSEcCtD
Vorinostat—NCOR1—Metabolism—HPGDS—testicular cancer	0.000412	0.00142	CbGpPWpGaD
Vorinostat—Alopecia—Doxorubicin—testicular cancer	0.000411	0.00117	CcSEcCtD
Vorinostat—Cough—Methotrexate—testicular cancer	0.000408	0.00116	CcSEcCtD
Vorinostat—Vomiting—Etoposide—testicular cancer	0.000405	0.00115	CcSEcCtD
Vorinostat—Anaemia—Epirubicin—testicular cancer	0.000404	0.00115	CcSEcCtD
Vorinostat—HDAC9—Disease—KITLG—testicular cancer	0.000401	0.00138	CbGpPWpGaD
Vorinostat—Headache—Etoposide—testicular cancer	0.000399	0.00114	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—testicular cancer	0.000398	0.00113	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—testicular cancer	0.000396	0.00113	CcSEcCtD
Vorinostat—Syncope—Epirubicin—testicular cancer	0.000392	0.00112	CcSEcCtD
Vorinostat—Leukopenia—Epirubicin—testicular cancer	0.000391	0.00112	CcSEcCtD
Vorinostat—HDAC3—Disease—H2AFZ—testicular cancer	0.000391	0.00135	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—H2AFZ—testicular cancer	0.000391	0.00134	CbGpPWpGaD
Vorinostat—Muscle spasms—Doxorubicin—testicular cancer	0.000389	0.00111	CcSEcCtD
Vorinostat—HDAC6—Signaling Pathways—STK11—testicular cancer	0.000388	0.00134	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—H2AFZ—testicular cancer	0.000387	0.00133	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—KIT—testicular cancer	0.000387	0.00133	CbGpPWpGaD
Vorinostat—Loss of consciousness—Epirubicin—testicular cancer	0.000384	0.00109	CcSEcCtD
Vorinostat—Cough—Epirubicin—testicular cancer	0.000382	0.00109	CcSEcCtD
Vorinostat—HDAC6—Disease—FGFR3—testicular cancer	0.000381	0.00131	CbGpPWpGaD
Vorinostat—Infection—Methotrexate—testicular cancer	0.000379	0.00108	CcSEcCtD
Vorinostat—Nausea—Etoposide—testicular cancer	0.000378	0.00108	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—testicular cancer	0.000374	0.00107	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—testicular cancer	0.000373	0.00106	CcSEcCtD
Vorinostat—Chest pain—Epirubicin—testicular cancer	0.000372	0.00106	CcSEcCtD
Vorinostat—Dry mouth—Epirubicin—testicular cancer	0.000364	0.00104	CcSEcCtD
Vorinostat—Anorexia—Methotrexate—testicular cancer	0.000363	0.00104	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—testicular cancer	0.000363	0.00103	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—testicular cancer	0.000362	0.00103	CcSEcCtD
Vorinostat—HDAC3—Disease—KITLG—testicular cancer	0.00036	0.00124	CbGpPWpGaD
Vorinostat—NCOR1—Disease—H2AFZ—testicular cancer	0.00036	0.00124	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KITLG—testicular cancer	0.000359	0.00124	CbGpPWpGaD
Vorinostat—Loss of consciousness—Doxorubicin—testicular cancer	0.000356	0.00101	CcSEcCtD
Vorinostat—Infection—Epirubicin—testicular cancer	0.000354	0.00101	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—H2AFZ—testicular cancer	0.000353	0.00122	CbGpPWpGaD
Vorinostat—Cough—Doxorubicin—testicular cancer	0.000353	0.00101	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—STK11—testicular cancer	0.000351	0.00121	CbGpPWpGaD
Vorinostat—Shock—Epirubicin—testicular cancer	0.000351	0.001	CcSEcCtD
Vorinostat—HDAC6—Disease—KIT—testicular cancer	0.00035	0.0012	CbGpPWpGaD
Vorinostat—Thrombocytopenia—Epirubicin—testicular cancer	0.000349	0.000995	CcSEcCtD
Vorinostat—HDAC4—Disease—FGFR3—testicular cancer	0.000345	0.00119	CbGpPWpGaD
Vorinostat—Chest pain—Doxorubicin—testicular cancer	0.000344	0.000981	CcSEcCtD
Vorinostat—Anorexia—Epirubicin—testicular cancer	0.00034	0.000969	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—testicular cancer	0.000337	0.00096	CcSEcCtD
Vorinostat—Decreased appetite—Methotrexate—testicular cancer	0.000331	0.000944	CcSEcCtD
Vorinostat—NCOR1—Disease—KITLG—testicular cancer	0.000331	0.00114	CbGpPWpGaD
Vorinostat—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000329	0.000938	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—testicular cancer	0.000329	0.000937	CcSEcCtD
Vorinostat—Infection—Doxorubicin—testicular cancer	0.000328	0.000935	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—H2AFZ—testicular cancer	0.000326	0.00112	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—STK11—testicular cancer	0.000326	0.00112	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KITLG—testicular cancer	0.000325	0.00112	CbGpPWpGaD
Vorinostat—Shock—Doxorubicin—testicular cancer	0.000325	0.000925	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—STK11—testicular cancer	0.000324	0.00112	CbGpPWpGaD
Vorinostat—Thrombocytopenia—Doxorubicin—testicular cancer	0.000323	0.000921	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—FGFR3—testicular cancer	0.000319	0.0011	CbGpPWpGaD
Vorinostat—HDAC8—Disease—FGFR3—testicular cancer	0.000318	0.0011	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KIT—testicular cancer	0.000317	0.00109	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—H2AFZ—testicular cancer	0.000316	0.00109	CbGpPWpGaD
Vorinostat—Anorexia—Doxorubicin—testicular cancer	0.000315	0.000897	CcSEcCtD
Vorinostat—Decreased appetite—Epirubicin—testicular cancer	0.00031	0.000884	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000308	0.000878	CcSEcCtD
Vorinostat—Fatigue—Epirubicin—testicular cancer	0.000308	0.000876	CcSEcCtD
Vorinostat—Constipation—Epirubicin—testicular cancer	0.000305	0.000869	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—H2AFZ—testicular cancer	0.000305	0.00105	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STK11—testicular cancer	0.000303	0.00104	CbGpPWpGaD
Vorinostat—Body temperature increased—Methotrexate—testicular cancer	0.000301	0.000859	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—KITLG—testicular cancer	0.0003	0.00103	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—STK11—testicular cancer	0.000299	0.00103	CbGpPWpGaD
Vorinostat—HDAC9—Disease—FGFR3—testicular cancer	0.000298	0.00102	CbGpPWpGaD
Vorinostat—HDAC1—Disease—H2AFZ—testicular cancer	0.000293	0.00101	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—KIT—testicular cancer	0.000293	0.00101	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KIT—testicular cancer	0.000292	0.00101	CbGpPWpGaD
Vorinostat—Decreased appetite—Doxorubicin—testicular cancer	0.000287	0.000818	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000285	0.000812	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—testicular cancer	0.000285	0.000811	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—testicular cancer	0.000282	0.000804	CcSEcCtD
Vorinostat—Body temperature increased—Epirubicin—testicular cancer	0.000282	0.000804	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—KITLG—testicular cancer	0.000281	0.000965	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—H2AFZ—testicular cancer	0.000274	0.000943	CbGpPWpGaD
Vorinostat—Asthenia—Methotrexate—testicular cancer	0.000274	0.000779	CcSEcCtD
Vorinostat—HDAC9—Disease—KIT—testicular cancer	0.000273	0.000941	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STK11—testicular cancer	0.000272	0.000937	CbGpPWpGaD
Vorinostat—Pruritus—Methotrexate—testicular cancer	0.00027	0.000769	CcSEcCtD
Vorinostat—HDAC1—Disease—KITLG—testicular cancer	0.00027	0.000928	CbGpPWpGaD
Vorinostat—HDAC3—Disease—FGFR3—testicular cancer	0.000268	0.00092	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—FGFR3—testicular cancer	0.000267	0.000919	CbGpPWpGaD
Vorinostat—Body temperature increased—Doxorubicin—testicular cancer	0.000261	0.000744	CcSEcCtD
Vorinostat—Diarrhoea—Methotrexate—testicular cancer	0.000261	0.000743	CcSEcCtD
Vorinostat—Asthenia—Epirubicin—testicular cancer	0.000256	0.000729	CcSEcCtD
Vorinostat—Pruritus—Epirubicin—testicular cancer	0.000252	0.000719	CcSEcCtD
Vorinostat—Dizziness—Methotrexate—testicular cancer	0.000252	0.000718	CcSEcCtD
Vorinostat—HDAC3—Signaling Pathways—KITLG—testicular cancer	0.000252	0.000867	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—H2AFZ—testicular cancer	0.000252	0.000866	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STK11—testicular cancer	0.00025	0.000861	CbGpPWpGaD
Vorinostat—NCOR1—Disease—FGFR3—testicular cancer	0.000246	0.000846	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KIT—testicular cancer	0.000246	0.000845	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KIT—testicular cancer	0.000245	0.000844	CbGpPWpGaD
Vorinostat—Diarrhoea—Epirubicin—testicular cancer	0.000244	0.000696	CcSEcCtD
Vorinostat—Vomiting—Methotrexate—testicular cancer	0.000242	0.000691	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—FGFR3—testicular cancer	0.000242	0.000831	CbGpPWpGaD
Vorinostat—Headache—Methotrexate—testicular cancer	0.000239	0.000681	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—testicular cancer	0.000237	0.000675	CcSEcCtD
Vorinostat—Dizziness—Epirubicin—testicular cancer	0.000236	0.000672	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—testicular cancer	0.000234	0.000666	CcSEcCtD
Vorinostat—NCOR1—Signaling Pathways—KITLG—testicular cancer	0.000232	0.000797	CbGpPWpGaD
Vorinostat—Vomiting—Epirubicin—testicular cancer	0.000227	0.000646	CcSEcCtD
Vorinostat—Nausea—Methotrexate—testicular cancer	0.000226	0.000645	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—testicular cancer	0.000226	0.000644	CcSEcCtD
Vorinostat—NCOR1—Disease—KIT—testicular cancer	0.000226	0.000776	CbGpPWpGaD
Vorinostat—Headache—Epirubicin—testicular cancer	0.000224	0.000637	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—FGFR3—testicular cancer	0.000223	0.000767	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KIT—testicular cancer	0.000222	0.000763	CbGpPWpGaD
Vorinostat—Dizziness—Doxorubicin—testicular cancer	0.000218	0.000622	CcSEcCtD
Vorinostat—Nausea—Epirubicin—testicular cancer	0.000212	0.000604	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—testicular cancer	0.00021	0.000598	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—FGFR3—testicular cancer	0.000209	0.000717	CbGpPWpGaD
Vorinostat—Headache—Doxorubicin—testicular cancer	0.000207	0.000589	CcSEcCtD
Vorinostat—HDAC1—Signaling Pathways—H2AFZ—testicular cancer	0.000205	0.000706	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KIT—testicular cancer	0.000205	0.000704	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STK11—testicular cancer	0.000204	0.000702	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—H2AFZ—testicular cancer	0.000203	0.0007	CbGpPWpGaD
Vorinostat—HDAC1—Disease—FGFR3—testicular cancer	0.0002	0.000689	CbGpPWpGaD
Vorinostat—Nausea—Doxorubicin—testicular cancer	0.000196	0.000559	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—KIT—testicular cancer	0.000191	0.000659	CbGpPWpGaD
Vorinostat—HDAC2—Disease—H2AFZ—testicular cancer	0.000189	0.00065	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KITLG—testicular cancer	0.000189	0.00065	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—FGFR3—testicular cancer	0.000187	0.000644	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KIT—testicular cancer	0.000184	0.000633	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KITLG—testicular cancer	0.000174	0.000598	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—FGFR3—testicular cancer	0.000172	0.000592	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KIT—testicular cancer	0.000172	0.000592	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KIT—testicular cancer	0.000158	0.000544	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FGFR3—testicular cancer	0.00014	0.000483	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—H2AFZ—testicular cancer	0.000132	0.000455	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STK11—testicular cancer	0.000131	0.000452	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FGFR3—testicular cancer	0.000129	0.000444	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KIT—testicular cancer	0.000129	0.000443	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KITLG—testicular cancer	0.000122	0.000419	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KIT—testicular cancer	0.000119	0.000408	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGFR3—testicular cancer	9.04e-05	0.000311	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KIT—testicular cancer	8.3e-05	0.000286	CbGpPWpGaD
